8VC

8VC, established in 1969 and headquartered in San Francisco, is a venture capital firm that invests in early-stage companies across various sectors, with a focus on enabling industry transformation. The firm, which is a Registered Investment Adviser, partners with founders to develop transformational technologies, targeting sectors such as healthcare, logistics, biology, IT infrastructure, and government & defense. 8VC aims to create long-term economic and societal value through its investments, promoting innovation and global prosperity.

Serena Ge

Campus Associate

Bhaskar Ghosh

Partner and CTO

Francisco Gimenez

Partner

Jin-Young Kim

Partner

Alex Kolicich

Founding Partner

Seth Lieblich

Principal

Jake Medwell

Co-Founder and Partner

Alex Moore

Partner

David Moskowitz

Principal

Allison Pavlick

Principal

Justin Rose

Associate

Kimmy Scotti

Founding Partner

Past deals in Early Venture Stage

Glimpse

Series A in 2025
Glimpse is a company founded in 2020 by Kushal Negi, Akash Raju, and Anuj Mehta, based in New York. The company specializes in partnering with brands to place their products in luxury short-term rentals, providing an innovative sales and acquisition channel. In addition, Glimpse has developed artificial intelligence automation tools tailored for consumer packaged goods (CPG) sales and operations teams. These tools facilitate automated purchase order data entry from retailers, proactively identify inventory issues, and enhance buyer engagement. By streamlining data entry and communication processes, Glimpse helps businesses improve order management and extract valuable insights from retail data.

Lumber

Series A in 2025
Lumber is a technology company specializing in construction workforce management. It offers an automated platform that streamlines payroll, time tracking, accounts payable, compliance, and onboarding processes for construction businesses. The platform leverages artificial intelligence and automation to provide contractors with enhanced control over their operations and simplified finance management.

Patlytics

Series A in 2025
Patlytics is a technology company that specializes in developing an artificial intelligence-powered platform tailored for the entire patent lifecycle. The platform provides a comprehensive suite of features, including patent drafting, prosecution, and litigation readiness, as well as competitive landscape scans and real-time alerts and reports. By integrating advanced analytics and comparison tools, Patlytics aims to enhance the efficiency of patent workflows, helping businesses to better manage their intellectual property portfolios and maintain a competitive edge in the market.

Latent Labs

Series A in 2025
Latent Labs is a pioneering AI laboratory specializing in programmable biology. It develops advanced generative AI models that capture the core principles of biology, empowering healthcare partners to create novel antibodies, optimize existing enzymes, and advance genetic engineering. This enables partners to gain unparalleled control over molecular biology, driving transformative advancements in health and sustainability.

Coram AI

Series A in 2025
Coram AI is a developer of advanced video intelligence systems that transform traditional camera technology into tools for operational enhancement. By providing businesses with the ability to gain valuable insights into their daily operations, security, and safety, Coram AI's platform enables organizations of all sizes to leverage their existing camera infrastructure more effectively. The company’s innovative approach allows clients to utilize their cameras not merely as recording devices but as intelligent systems that contribute to operational improvements and enhanced situational awareness.

Overland AI

Series A in 2025
Overland AI specializes in the development and manufacturing of autonomous navigation technologies for off-road vehicles. The company focuses on creating artificial intelligence-based solutions that enhance navigation and transportation capabilities in mission-critical sectors, including defense and national security. By leveraging machine learning and robotic systems, Overland AI offers modular software solutions that facilitate autonomous operation in challenging environments, such as mines, construction sites, and disaster zones. Its innovations aim to enable users to navigate unimproved roads and complex terrains effectively, thereby improving operational efficiency and safety in diverse applications.

Reveal Technology

Series A in 2024
Reveal Technology is a visual analytics and edge artificial intelligence company that focuses on enhancing situational awareness for defense and public safety teams. The company has developed a platform that integrates advanced AI-driven technologies to deliver real-time two-dimensional and three-dimensional mapping and tactical insights. This technology enables operators to achieve decision dominance in mission-critical environments while also reducing emissions signatures. Through its innovative solutions, Reveal Technology aims to empower teams with the tools necessary for effective decision-making in complex situations.

Seen Health

Series A in 2024
Seen Health is a healthcare firm dedicated to empowering older adults to age with dignity in their communities. The company specializes in culturally-focused, technology-enabled healthcare services that integrate medical care and social support. By utilizing the Program of All-Inclusive Care for the Elderly (PACE) model, Seen Health aims to provide quality care tailored to the needs of older adults, ensuring they receive comprehensive support in a manner that respects their cultural backgrounds and personal preferences.

Even

Series A in 2024
Even is a health tech company that provides comprehensive health coverage services through a subscription model. By partnering with leading hospitals, it offers unlimited access to diagnostics, consultations, and substantial hospitalization coverage for a fixed monthly fee. Even streamlines the healthcare experience with a claimless reimbursement process, directly transferring funds to partner hospitals on behalf of its members. This approach allows individuals to efficiently address their long-term health needs while simplifying the often complex healthcare payment process.

Numeric

Series A in 2024
Companies rely on Numeric to ensure their financial data is accurate, automate the month-end close, and generate real-time insights. Rated 4.9 / 5 on G2

Amber Therapeutics

Series A in 2024
Amber Therapeutics is a biotechnology company that specializes in developing advanced bioelectrical therapies aimed at treating functional disorders of the peripheral nervous system. The company creates a bioelectronic platform that delivers closed-loop bioelectrical treatments, which can sense and adapt to the patient's needs while also providing stimulation. By focusing on conditions such as mixed urinary incontinence, Amber Therapeutics seeks to enhance clinical efficacy and patient outcomes through innovative approaches that emphasize the peripheral nervous system rather than the central nervous system. Its technology has the potential to significantly improve treatment methods and overall patient care in targeted disease areas.

iCOMAT

Series A in 2024
iCOMAT is a pioneering company that specializes in advanced carbon fiber composite manufacturing technologies, specifically through its patented Rapid Tow Shearing (RTS) process. This innovative technology is the first of its kind to enable defect-free fiber steering, allowing for the placement of carbon fiber tapes along curved paths. This capability not only enhances the structural performance of composite materials but also leads to the production of lighter, stronger, and more cost-effective components. By optimizing the mechanical properties at various points in a structure, iCOMAT's systems facilitate the creation of ultra-lightweight composite structures that surpass the limitations of traditional manufacturing methods. The company serves key sectors, including aerospace, automotive, and marine, driving improvements in product performance while significantly reducing raw material usage and production costs. As a market leader in automated composite manufacturing, iCOMAT is positioned to revolutionize various industries by delivering advanced lightweighting solutions that meet the evolving demands of modern engineering.

Luminate Medical

Venture Round in 2024
Luminate Medical is a company focused on developing innovative medical devices aimed at preventing hair loss during chemotherapy. Recognizing the significant impact that hair loss can have on a patient's self-esteem and sense of identity, Luminate Medical is committed to leveraging advanced medical technology to address this issue. The company offers a unique, portable, and comfortable wearable system designed to help patients maintain their confidence and dignity throughout their cancer treatment, ultimately enabling them to manage and mitigate the side effects associated with chemotherapy.

Latus Bio

Series A in 2024
Latus Bio is a biotechnology company dedicated to developing innovative gene therapies for neurological diseases. It specializes in novel discovery approaches using non-human primate models, enabling precise delivery of therapeutic genes to targeted cells within the central nervous system. Latus Bio aims to enhance clinical safety and manufacturing efficiency by administering low doses of its proprietary adeno-associated virus (AAV) capsids.

Amae Health

Series A in 2024
Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Edia Learning

Series A in 2024
Edia is an EdTech platform for 6-12 Math that ensures superior state test outcomes.

Campus

Series A in 2024
Campus is an accredited online community college dedicated to providing accessible higher education through its online learning services. The institution offers a range of associate degree and certificate programs, delivered both live online and in person. Campus prioritizes student success by making community college education available nationwide, ensuring that students have the flexibility and support needed to achieve their educational goals.

Lightbeam.ai

Series A in 2024
LightBeam.ai is a leading innovator in data security and privacy automation, dedicated to helping organizations manage and access sensitive data securely. The company's platform utilizes advanced data management techniques, including entity linkage and deep learning, to efficiently scan and comprehend documents, speech, and natural language processing at scale. This technology operates seamlessly across various third-party virtual clouds or managed services, allowing clients to integrate data from diverse sources and generate actionable insights while safeguarding data privacy and confidentiality. LightBeam.ai empowers privacy and compliance executives to maintain continuous compliance, while also providing information security executives with assurance that sensitive data is accessed and utilized securely. Through its identity-centric discovery and classification engine, LightBeam integrates data cataloging, access, and sharing into a cohesive privacy control system.

Harbor Health

Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, established in 2022. The company focuses on delivering personalized, patient-centered healthcare by leveraging technology to enhance the health experience. Harbor Health emphasizes a collaborative approach to care, co-creating individualized health paths that align with patients' specific health goals. It offers a range of services, including primary and specialty care, chronic disease management, and behavioral health. The clinic provides convenient access through same-day and virtual appointments, as well as accessible locations, ensuring that patients receive timely and comprehensive care tailored to their needs.

Cambium

Series A in 2023
Cambium is a company focused on developing biomaterials for various sectors, including defense, aerospace, and renewable energy. Established in 2019 and located in Berkeley, California, it specializes in advanced materials research and development. The company utilizes a combination of synthetic biology, materials science, and artificial intelligence to enhance material performance and sustainability. Cambium's approach involves vertically integrated innovation, ranging from computational material discovery to the production of advanced composites within the United States. By leveraging cutting-edge advancements across multiple scientific disciplines, Cambium aims to improve existing products and facilitate the creation of next-generation materials.

Samara

Series A in 2023
Samara is a home services company that specializes in home renovation, interior design, and architectural services. The firm operates a design studio aimed at enhancing living spaces by offering customized solutions for clients. Samara focuses on building homes and creating tailored backyards that accommodate studios and bedrooms, allowing clients to fully personalize their residences. Through its various services, the company seeks to improve the quality of living for its customers by transforming their homes into functional and aesthetically pleasing environments.

Saronic Technologies

Series A in 2023
Saronic Technologies specializes in the design and manufacture of advanced unmanned surface vehicles (USVs). These vehicles are equipped with cutting-edge hardware, software, and artificial intelligence, creating a scalable and integrated platform for enhancing maritime security and domain awareness. Tailored for defense and surveillance applications, Saronic's products offer comprehensive operational capabilities to naval and maritime forces.

Reserv

Series A in 2023
Reserv is a digital claims third-party administrator focused on optimizing property and casualty (P&C) claims through innovative technology solutions. The company develops modern systems designed to enhance the efficiency of the claims process, addressing critical resource challenges within the claims ecosystem. By offering solution-oriented products and services, Reserv aims to improve outcomes for users while ensuring compliance with insurance carriers. Additionally, the company serves as an incubator for testing new technologies and artificial intelligence services, driving advancements in claims innovation and operational effectiveness.

Endear Health

Series A in 2023
Endear Health is a technology company focused on addressing the healthcare needs of the aging population. It provides an online platform that serves as a single access point for Medicare-eligible individuals, enabling them to effectively manage their health and benefits. The platform is designed to be user-friendly, offering tools that help seniors collect and organize their health-related information. By doing so, Endear Health aims to empower older adults to overcome barriers in healthcare and take control of their health management.

Vital Bio

Venture Round in 2023
Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.

DataHub

Series A in 2023
DataHub Core is the #1 open source platform with a uniquely scalable and extensible metadata graph supporting manual and automated data management. DataHub Cloud is an enterprise-ready SaaS solution providing a fully-managed service of DataHub Core with additional AI-powered capabilities in discovery, observability, and governance to accelerate production-readiness of AI and data assets.

Myeloid Therapeutics

Series A in 2023
Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.

Empassion

Venture Round in 2023
Empassion Health is a company that specializes in comprehensive, community-based care for patients experiencing advanced illnesses. Founded in 2022, the company provides essential tools for managing patient care across various stages, including enrollment, care management, and coordination. Its services encompass primary and urgent care visits, goals planning, and social and spiritual care planning. Empassion Health aims to enhance the quality of life for patients, allowing them to maintain their well-being and independence in the comfort of their homes.

Chaos

Series A in 2023
Chaos Industries is a technology company dedicated to developing advanced solutions for defense and critical industries. The company specializes in detection and radar services, leveraging its innovative Coherent Distributed Networks (CDN) to improve sensing, detection, and communication capabilities across multiple platforms. By focusing on the needs of defense clients, Chaos Industries enhances product development and ensures the delivery of high-quality services tailored to the demands of the sector.

Atomic AI

Series A in 2023
Atomic AI is a company focused on advancing drug discovery through the innovative integration of machine learning and structural biology, specifically targeting RNA. The firm operates a content intelligence platform that facilitates the rational design of new molecules and medicines using artificial intelligence. By leveraging engagement data from clients' analytics, Atomic AI gathers valuable insights and generates predictive reports regarding relevant topics, optimal publishing times, and effective distribution channels. This approach equips users with strategies to develop therapies aimed at treating or curing diseases through the manipulation of RNA structures.

Oula Health

Series A in 2023
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Mantra Bio

Series A in 2023
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which integrates computational biology, wet lab techniques, and automation. This innovative approach leverages the diversity of exosomes to design and optimize therapeutics aimed at various tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process to ensure the reproducibility and high purity of its next-generation therapeutics, enabling medical practitioners to address challenging diseases effectively.

Second Front

Series A in 2022
Second Front Systems, Inc. is a technology company focused on enhancing government access to innovative, commercially developed technologies for national security applications. Founded in 2014 and headquartered in Arlington, Virginia, the company specializes in software solutions that facilitate the identification, assessment, and deployment of venture capital-backed technologies. Its primary product, Atlas Fulcrum, is a platform designed to streamline the discovery and engagement process for government users seeking advanced commercial technologies. Additionally, Second Front offers program management and system integration services to ensure the effective delivery of these technologies to military personnel. The company also operates the High Technology Council, an enterprise consortium that brings together key stakeholders to promote the application of venture-backed innovations in government-funded national security missions. With additional offices in Washington, D.C., and San Francisco, Second Front is positioned to transform how government entities access and utilize cutting-edge technology.

Telegraph

Series A in 2022
Telegraph is a Chicago-based company founded in 2020 that focuses on transforming the freight rail industry through its innovative cloud-based operating system. This platform enhances collaboration among railroads, shippers, and third-party logistics providers, allowing for improved visibility and insights into rail operations. By leveraging advanced technology, Telegraph aims to streamline workflows and logistics, ultimately fostering a more sustainable supply chain in the freight ecosystem. Its modern approach seeks to facilitate commerce and improve efficiency in rail operations, marking a significant advancement for the industry.

Surge Therapeutics

Series A in 2022
SURGE Therapeutics is a biotechnology company focused on enhancing cancer treatment outcomes through innovative immunotherapy solutions. It has developed a proprietary injectable biodegradable hydrogel designed to deliver cancer therapeutics in a prolonged and localized manner. This technology enables targeted release of immunotherapy agents at the surgical site following tumor resection, allowing for more effective treatment administration. By optimizing the timing and location of drug delivery, SURGE Therapeutics aims to improve patient survival rates and minimize systemic side effects, representing a significant advancement in the field of cancer care.

Invisible AI

Series A in 2022
Invisible AI Inc. is a company specializing in artificial intelligence-driven visual intelligence solutions for logistics and manufacturing sectors. Founded in 2018 and headquartered in San Francisco, it develops low-cost, low-bandwidth cameras that monitor operations in real-time at various workstations. These smart cameras capture human motion, enabling the analysis of workforce movements to identify and mitigate manual assembly errors, thereby improving quality, productivity, and safety. Invisible AI provides a web dashboard that integrates and visualizes data, offering clients valuable insights to optimize workflows and ensure operational processes are executed correctly and safely. With its edge-based system, the company aims to enhance operational efficiency and reduce manufacturing costs for its clients.

Jacobi

Series A in 2022
Jacobi, Inc. is a technology company that specializes in providing a customizable platform for the modeling and visualization of multi-asset portfolios. Founded in 2014 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, and London, United Kingdom, Jacobi offers tools that streamline investment processes, enabling users to design, analyze, and engage with portfolios effectively. The platform aggregates portfolios and cash flows, allowing for the creation of comprehensive dashboards that facilitate intuitive visualizations of complex financial data. By enabling deeper analysis of risk and returns associated with investment decisions, Jacobi enhances communication between investment managers and their clients. The company was previously known as Think Future, Inc. and continues to develop solutions that foster better investment ideas and engagement through storytelling and analytics.

Opto Investments

Series A in 2022
Opto Investments is a private equity firm based in New York, established in 2020. The company provides a comprehensive platform designed for independent investment advisors, enabling them to access private market investments. Opto connects these advisors with top-performing managers and offers a full suite of alternative asset tools, accompanied by expert insights. This approach aims to enhance revenue generation for clients while facilitating access to private investment opportunities, ultimately supporting long-term wealth building.

Rephrase.ai

Series A in 2022
Rephrase.ai is a technology company that specializes in video creation through its AI-powered visual dubbing tool. The company has developed innovative technology that transforms any piece of text into a video featuring a person speaking that text. By utilizing generative AI, Rephrase.ai's system learns and reconstructs photorealistic facial features corresponding to spoken audio, allowing for the creation of customized videos. This capability enables clients to produce training videos, personalize sales content, animate characters in augmented and virtual reality, and give a face to digital assistants. Rephrase.ai's solutions cater to a variety of applications, enhancing communication and engagement through dynamic visual content.

Harbor Health

Series A in 2022
Harbor Health is a multi-specialty clinic group based in Austin, Texas, established in 2022. The company focuses on delivering personalized, patient-centered healthcare by leveraging technology to enhance the health experience. Harbor Health emphasizes a collaborative approach to care, co-creating individualized health paths that align with patients' specific health goals. It offers a range of services, including primary and specialty care, chronic disease management, and behavioral health. The clinic provides convenient access through same-day and virtual appointments, as well as accessible locations, ensuring that patients receive timely and comprehensive care tailored to their needs.

Photys Therapeutics

Series A in 2022
Photys Therapeutics is a biopharmaceutical company focused on developing bifunctional small molecules that provide precise control over protein post-translational modifications. This innovative platform allows for the restoration of protein function, repair of cellular signaling pathways, and enhancement of the body's natural disease-fighting abilities. Co-founded by prominent chemist Amit Choudhary from the Broad Institute and the Longwood Fund, Photys is supported by a scientific advisory board that includes renowned experts from institutions such as MIT, Salk Institute, and Berkeley. The company's unique approach aims to advance therapeutic options in the healthcare industry, particularly by targeting kinases and potentially phosphatases, to address various diseases effectively.

KeyCare

Series A in 2022
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.

Cartography Biosciences

Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company aims to revolutionize cancer immunotherapies by identifying the safest and most effective targets for treatment. Utilizing a platform-based cell therapy approach, Cartography employs single-cell analysis to discover novel CAR-T targets. This methodology empowers clients to enhance their molecular biology and computational methods, facilitating the advancement of innovative cancer immunotherapies. By prioritizing precision and safety, Cartography Biosciences is dedicated to transforming the landscape of cancer treatment.

Fruitful

Series A in 2022
Fruitful is a financial wellness platform focused on empowering individuals to manage their finances more effectively. It offers personalized financial advice from qualified specialists and hands-on investment management. The platform simplifies the banking experience by integrating commonly used third-party apps, bank accounts, and financial services into a single dashboard. This subscription-based model equips users with banking tools that enhance financial understanding and promote a secure financial future. Additionally, Fruitful provides access to ultra-high-yield savings, further supporting its members in taking greater control over their money.

Felux

Series A in 2022
Felux is a B2B marketplace and supply chain platform specifically designed for the mining industry. The company provides a comprehensive suite of services that includes procurement solutions and supply chain management. Its platform facilitates the buying and selling of industrial products, allowing users to source, procure, ship, finance, and analyze transactions related to steel and other materials in one centralized location. This digital approach enables suppliers to efficiently manage their selling and distribution processes while enhancing commerce within the industrial sector.

Seaplane IO

Series A in 2022
Seaplane IO Inc. is a technology company that specializes in developing a serverless cloud software system tailored for modern enterprises. Founded in 2020 and headquartered in Mountain View, California, Seaplane IO enables developers to create and scale applications globally without the complexities of managing cloud infrastructure. The company's platform supports on-premises and cloud server deployments, allowing for secure code execution from any location. By harnessing the capabilities of multi-cloud and edge computing, Seaplane IO provides the necessary APIs, services, and support to help software developers deliver optimal application performance to users worldwide.

Candid Health

Series A in 2022
Candid Health is a developer of an innovative platform that automates the revenue cycle management process for healthcare providers. By utilizing machine learning and artificial intelligence, Candid Health streamlines essential tasks such as medical billing, coding, and claims processing. The platform is designed for seamless integration with existing healthcare infrastructure, allowing providers to efficiently manage the complexities of medical billing. This automation reduces administrative burdens and enhances operational efficiency, enabling healthcare facilities to focus on delivering high-quality, affordable, and accessible care to patients. Candid Health's end-to-end solution also aims to improve the overall patient experience by ensuring faster reimbursement and better management of financial operations.

Fieldguide

Series A in 2022
Fieldguide, Inc. is an enterprise software company that specializes in automation and collaboration solutions for audit and advisory firms. Established in 2020 and based in Sacramento, California, Fieldguide's platform digitizes the entire project lifecycle, offering features such as secure data requests, work plan management, reporting automation, and resource planning. The software utilizes artificial intelligence to standardize templates and streamline data management, facilitating efficient report creation. By enhancing workflow processes, Fieldguide aims to help firms improve margins, attract new business, and strengthen client relationships, ultimately empowering productivity and revenue growth in the assurance and advisory sectors.

OpenComp

Series A in 2022
OpenComp is a compensation intelligence platform designed to assist high-growth companies in making informed business decisions regarding their compensation practices. Founded in 2021 by Thanh Nguyen and Nancy Connery, both former members of Salesforce's founding HR team, OpenComp serves over 2,000 organizations, including notable names such as Calm, Discord, and Reddit. The platform provides tools that enable companies to assess the impact of compensation changes on financial metrics, while also offering data analysis for benchmarking by gender and ethnicity within the workforce. OpenComp's services are available at no cost for organizations with up to 50 employees, with tiered pricing options for larger companies based on their size and specific needs. The company has secured $24 million in venture capital from investors including J.P. Morgan and TIME Ventures.

Standard Metrics

Series A in 2022
Standard Metrics is an automated financial cooperation platform designed to enhance decision-making for investors and creators. By eliminating data silos found in spreadsheets and outdated applications, the platform provides seamless access to comprehensive firm data across portfolios, including financial metrics and investment information. It facilitates real-time engagement between teams and founders, ensuring financial transparency and effective communication. The platform automates data collection and centralizes portfolio information, enabling detailed analysis and insights. This empowers founders to make informed decisions aimed at scaling their companies and maximizing returns.

180° Insurance

Series A in 2022
180° is an InsurTech company that provides insurance services. With a focus on the B2B2C model, the company builds insurance and assistance products with technology that are connected to customers' daily lives in a simple and digital way. 180° was founded in 2020 and is headquartered in Sao Paulo, Brazil.

Cellino

Series A in 2022
Cellino is focused on developing a scalable, automated biomanufacturing system aimed at producing personalized cell therapies. The company's innovative platform leverages AI-guided laser editing to generate autologous induced pluripotent stem cells (iPSCs) efficiently and at scale. By utilizing image-guided machine learning, single-cell laser processing, and robotics, Cellino seeks to make advanced, potentially curative treatments accessible for a range of chronic degenerative diseases, including vision loss and Parkinson's disease. The company's mission is to transform healthcare by enabling personalized therapies that can significantly improve patient outcomes and overall health.

Rocketlane

Series A in 2022
Rocketlane is a developer of a customer onboarding platform that focuses on enhancing the implementation and onboarding process for professional services teams. The platform is designed to streamline and accelerate project execution by facilitating collaboration, time tracking, and resource management. Rocketlane enables businesses to deliver onboarding projects in a transparent and efficient manner, ensuring a consistent execution strategy that enhances the overall customer experience. Its clientele includes notable companies such as Clari, Drift, Icertis, Showpad, Uniphore, and Vidyard, among others. By improving communication and visibility across projects, Rocketlane helps organizations achieve better governance and deliver valuable results for their clients.

Ritten

Venture Round in 2022
Ritten is a company that provides an electronic medical records platform specifically designed for addiction treatment providers. Its platform enhances the quality of care by allowing clinicians and administrators to deliver personalized, data-informed treatment. Ritten's solution features customizable workflow configurations, which facilitate the consistent and compliant delivery of complex treatment. The platform enables healthcare professionals to maintain comprehensive patient records that encompass all dimensions of care, including clinical notes, medications, and treatment plans. Through its innovative approach, Ritten aims to improve outcomes for patients in addiction treatment settings.

Software.com

Series A in 2021
Software.com is an online retailer of software solutions located in Manhattan Beach, California. As a subsidiary of Internet Real Estate Group, LLC, the company focuses on transforming software development by quantifying the craft through data collection across various stages of the development process. By providing insights and analytics, Software.com aims to assist developers and teams in improving productivity and coding efficiency.

Petra

Series A in 2021
Petra is a robotics company specializing in underground utility solutions. The firm has developed advanced tunneling robots designed to efficiently and safely bore utility conduits through various geological conditions, including high-grade hard rock. By enabling the undergrounding of critical utilities, Petra provides a practical and cost-effective means to construct small-diameter infrastructure, particularly in disaster-prone areas. Their technology addresses the challenges of traditional tunneling methods, making it feasible to install essential utilities in previously inaccessible locations.

Elegen

Series A in 2021
Elegen is a biotechnology company founded in 2017 and led by Dr. Matthew Hill, specializing in the development of microfluidic technology. The company focuses on creating innovative DNA synthesizers that enhance the engineering of entire genomes. By leveraging its advanced technology, Elegen aims to accelerate biomedical advancements and facilitate DNA sequence testing within the healthcare industry. Through its commitment to disrupting synthetic biology, Elegen is positioned to play a pivotal role in the future of genetic research and applications.

Surglogs

Series A in 2021
SurgLogs Inc. is a software developer based in San Diego, California, specializing in compliance-related solutions for ambulatory surgery centers and healthcare facilities. Founded in 2015, the company provides a digital platform that replaces traditional pen-and-paper methods with a HIPAA-compliant application and an administrative dashboard. This platform organizes and automates the management of logbooks, medications, supplies, in-services, and drills, enhancing efficiency and reducing paperwork for healthcare organizations. SurgLogs offers features such as device authorization, automated daily checks and notifications, and electronic report export services, catering to doctors, nurses, and healthcare administrators. By streamlining compliance processes, SurgLogs enables its clients to maintain regulatory standards effectively and manage operations more efficiently.

Quince

Series A in 2021
Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

Spartan Radar

Series A in 2021
Spartan Radar is a developer of advanced radar technology that creates high-resolution real-time radar imagery, utilizing proprietary software algorithms. The company's approach incorporates machine learning and edge-processing, mimicking human perceptual abilities to enhance the detection and response to obstacles. Spartan's platform improves the performance of existing advanced driver-assistance systems (ADAS) by increasing resolution, response time, and range, while maintaining affordability and minimizing computational demands. With a foundation built on decades of expertise in commercializing aerospace and automotive technologies, Spartan Radar provides cutting-edge radar solutions for various applications, including drones and vehicles.

Better Health

Series A in 2021
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.

Mindbloom

Series A in 2021
Mindbloom is a Seattle-based mental health and wellbeing company that specializes in at-home, clinician-prescribed psychedelic therapies, particularly guided ketamine treatment for anxiety and depression. The company aims to facilitate personal and clinical breakthroughs by providing science-backed therapies designed by leading psychiatrists and supported by expert guides. Mindbloom’s platform connects clients with licensed clinicians who assess their health history to ensure appropriate treatment. By leveraging behavioral science and innovative engagement techniques, Mindbloom makes personal growth accessible and effective, enhancing the quality of life for its users. The company has garnered a user base of over 30,000 and has established partnerships with organizations such as Aetna and Sacramento State University, along with research collaborations with prominent institutions like UC Santa Barbara and Stanford.

Esper

Series A in 2021
Esper is a company that specializes in developing a policy collaboration platform aimed at enhancing the policymaking process within government entities. By providing software that allows government officials to integrate, manage, and analyze policy data, Esper facilitates transparent and data-driven decision-making. The company collaborates with numerous government agencies, including the New York City Police Department, Washington Department of Health, and California State Treasurer’s Office, to streamline internal workflows and support the entire policymaking lifecycle. With a workforce of over 30 employees, Esper has raised more than $14 million in funding to further its mission of creating a unified source of truth for public policy.

Formlogic

Series A in 2021
Formlogic is an autonomous manufacturing technology company focused on delivering precision components for the space and frontier industries. By addressing the challenges of the domestic supply chain, Formlogic enhances manufacturing capabilities, allowing both novice and expert workers to achieve high levels of precision and productivity. The company's technology enables rapid turnaround times for custom machined components, with production orders completed in weeks rather than months. Additionally, Formlogic provides real-time order status updates, improving the overall customer experience. Through its innovative approach, Formlogic aims to revolutionize the manufacturing process, ensuring close tolerances and efficient production at scale.

Appia Bio

Series A in 2021
Appia Bio is a biotechnology company dedicated to the research and development of off-the-shelf allogeneic cell therapies, with a particular focus on engineered allogeneic cell therapies for various medical indications. The company utilizes its proprietary ACUA technology platform to harness the biology of lymphocyte development, integrating chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering. This innovative approach allows Appia Bio to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells (HSCs). By maturing and scaling healthy stem cells into invariant T-cell therapies, Appia Bio aims to provide physicians with safe and targeted cancer treatment options, thereby expanding patient access to advanced therapeutic solutions.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on advancing health through innovative applications of microbial sciences. The company develops health supplements that combine probiotics and prebiotics, targeting various aspects of well-being, including digestive health, skin health, heart health, and micronutrient synthesis. By collaborating with academic researchers, Seed Health aims to bring breakthrough discoveries to market, offering consumers live biotherapeutics designed to enhance both human and environmental health.

Polly

Series A in 2021
PollyEx, Inc. operates a loan trading platform focused on the mortgage capital markets, facilitating transactions between buyers and sellers of mortgage loans. Founded in 2017 and based in San Francisco, California, PollyEx enhances loan sale execution through its cloud-based platform, which integrates with buyers and sellers via API, thereby increasing liquidity and automating various functions within capital markets. The platform aims to provide pricing transparency and improve operational efficiency for lenders, enabling them to make informed decisions throughout the lifecycle of a loan.

Polly

Series A in 2021
Polly is an anonymous polling application that allows users to create and share polls on social media platforms like Snapchat and Instagram. The app enables users to formulate questions and attach them to their stories, facilitating honest feedback from friends. By providing a fun and interactive way to gauge opinions, Polly encourages user engagement and fosters social interaction through its uniquely designed features.

Baton

Series A in 2021
Baton Trucking, Inc. is a logistics company based in San Francisco, California, that specializes in enhancing long-haul trucking efficiency through its innovative drop zone network. This network allows for the segmentation of long routes, facilitating the use of specialized vehicles for different sections of the journey. Additionally, Baton provides a real estate infrastructure designed for highway-only autonomous trucks to seamlessly interchange loads with human drivers for final-mile delivery. Incorporated in 2019, the company also operates a technology innovation laboratory that collaborates with Ryder System, focusing on a digital platform that utilizes optimization and artificial intelligence to streamline freight networks and reduce waste in trucking operations.

Elemy

Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Edgybees

Series A in 2021
Edgybees Ltd. is a technology company based in Palo Alto, California, founded in 2016. It specializes in developing an innovative platform that delivers real-time augmented reality experiences for high-speed applications, including drones, vehicles, and wearable devices. The platform utilizes sensors and streaming data to enable application developers to create immersive overlays that maintain synchronization with high-speed motion. Edgybees offers a range of industrial solutions tailored for sectors such as search and rescue, homeland security, real estate, construction, agriculture, and automotive. Additionally, the company provides gaming applications, including Droneprix AR and Sky Skreemers. With its unique, patent-pending capabilities and a developer SDK, Edgybees facilitates the creation of both commercial and consumer applications, enhancing the effectiveness of operations for military and emergency responders.

BigHat Biosciences

Series A in 2021
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.

Raydiant

Series A in 2021
Raydiant Inc., established in 2017 and headquartered in San Francisco, specializes in designing, developing, and providing an experience platform that connects employees and customers with brands across various industries such as banking, retail, hospitality, and healthcare. The company's solution comprises kiosks, virtual agents, and multimedia devices for screen management, enabling businesses to create engaging in-store experiences through digital signage. Raydiant works with over 5,000 brands worldwide, including notable clients like Johnson & Johnson and Chick-Fil-A, helping them streamline operations, enhance customer experiences, and drive sales growth.

Myeloid Therapeutics

Series A in 2021
Myeloid Therapeutics is an immunology company dedicated to leveraging innovative technologies to harness the potential of myeloid cells for the treatment of cancer and other diseases. The company has developed the ATAK platform, which focuses on reprogramming innate immune cells to enhance their ability to target and eliminate cancerous cells. Initially, Myeloid Therapeutics is advancing a cell therapy program aimed at treating T cell lymphoma, as well as a primed monocyte strategy for glioblastoma. The versatility of the ATAK platform allows for scalability across various treatment modalities and disease areas, facilitating collaboration with partners to expand its applications in the field of immunotherapy.

Kojo

Series A in 2020
Kojo is a cloud-based construction management software company that provides an all-in-one platform for contractors to manage their material and inventory needs. Founded in 2018 and based in San Francisco, Kojo's system focuses on streamlining materials management and procurement processes, enhancing profitability for construction companies. By integrating various stakeholders, including field teams, procurement, and distributors, Kojo simplifies the supply chain through automation, facilitating the ordering and tracking of materials. This approach enables contractors to ensure timely delivery of materials to job sites, thereby improving operational efficiency.

Cellares

Series A in 2020
Cellares Corporation, founded in 2019 and based in South San Francisco, California, specializes in the development of cell therapies for cancer treatment. The company addresses significant manufacturing challenges associated with these therapies, which are often produced on a per-patient basis, leading to high costs and limited availability. Cellares is pioneering the Cell Shuttle, an automated, closed end-to-end manufacturing solution designed to enhance the scalability and efficiency of cell therapy production. This innovative system allows for the simultaneous production of ten times more patient doses compared to traditional manual methods, while also reducing process failure rates by three-fold and lowering manufacturing costs by up to 70 percent. By providing flexible and scalable manufacturing options, Cellares aims to accelerate the delivery of life-saving therapies to patients in need and support the broader biopharmaceutical industry in meeting global demand for these treatments.

Twingate

Series A in 2020
Twingate Inc. is a technology company founded in 2018 and based in Redwood City, California, specializing in secure remote access solutions for organizations. The company offers a cloud-based platform designed to replace traditional Virtual Private Networks (VPNs) with a modern zero trust approach, which enhances security while maintaining usability for IT teams and end users. Twingate's technology enables employees to access private applications, data, and environments seamlessly, whether these resources are hosted on-premise or in the cloud. Key features include resource-level control, a centralized web-based administration console, split tunneling, and intelligent routing, all of which facilitate secure connections without the complexities associated with traditional deployment methods.

Dren Bio

Series A in 2020
Dren Bio is a biotechnology company that specializes in protein engineering technologies aimed at depleting pathogenic cells, protein aggregates, and other disease-causing agents. The company operates under a holding business model, developing a diverse portfolio of projects that function as stand-alone assets. Dren Bio's platform is designed to address a range of health conditions, including hematologic neoplasms, solid tumors, autoimmune disorders, and diseases associated with protein aggregation. By focusing on innovative protein-based technologies, Dren Bio enables healthcare professionals to manage and treat various serious diseases more effectively.

Sonoma Pharmaceuticals

Series A in 2020
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Woodstock, Georgia, focused on developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, dermatology, animal health, eye care, and oral care. With over 100 products commercialized in 33 countries, Sonoma addresses unmet medical needs through its innovative therapies aimed at chronic skin conditions. Key offerings include Epicyn, an antimicrobial facial cleanser; Levicyn, a prescription product for dermatoses; Celacyn gel for scar management; and SebuDerm for seborrheic dermatitis. Additionally, the company provides Microcyn, which targets various pathogens to promote wound healing, and Acuicyn, designed for eye care. Sonoma Pharmaceuticals was formerly known as Oculus Innovative Sciences, Inc. and has been incorporated since 1999. Its commitment to improving patient care and reducing healthcare costs is reflected in its diverse product portfolio that caters to both prescription and non-prescription needs.

Sonoma Biotherapeutics

Series A in 2020
Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.

Hexagon Bio

Series A in 2020
Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Sirona

Series A in 2020
Sirona Medical, Inc. is a technology company that has developed a cloud-native diagnostic engine tailored for radiologists. Founded in 2018 and headquartered in San Francisco, California, Sirona aims to revolutionize the field of radiology by providing a unified platform that integrates various essential tools, including a universal worklist, viewer, reporter, and AI capabilities. This innovative system simplifies complex workflows, enhances productivity, and allows practitioners to focus on patient care rather than administrative tasks. By streamlining operations and incorporating advanced AI technologies, Sirona empowers radiologists to work more efficiently and effectively, enabling them to deliver better and faster healthcare services.

Habi

Series A in 2020
Habi is a technology-driven real estate company based in Bogotá, Colombia, that specializes in simplifying the homeownership process for middle-class customers throughout Latin America. Founded in 2019, Habi utilizes a proprietary pricing algorithm and advanced analytical tools to facilitate quicker and more efficient transactions for buying and selling residential properties. By reducing the time required for sales and minimizing risks associated with traditional real estate processes, Habi eliminates the need for intermediaries and empowers clients with essential information. The company's innovative platform aims to enhance the overall experience of homeownership, making it more accessible and streamlined for its users.

High Definition Vehicle Insurance

Series A in 2020
HDVI is a technology-first commercial insurance provider. The company assesses risk using historical and real-time telematics data and provides tools and services that help fleets increase safety, rewards safe driving, and delivers efficient and fair claims processing. HDVI is headquartered in Chicago with additional offices in Greenville, South Carolina; Columbus, Ohio; Portland, Oregon; Dallas and San Francisco. High Definition Vehicle Insurance, Inc. is a licensed property casualty insurance agent with products underwritten by various insurance companies. For more information, visit https://hdvi.com.

Mantra Bio

Series A in 2020
Mantra Bio, Inc. is a biotechnology company focused on developing targeted therapeutics through its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). Founded in 2016 and based in San Francisco, California, the company utilizes its REVEAL platform, which integrates computational biology, wet lab techniques, and automation. This innovative approach leverages the diversity of exosomes to design and optimize therapeutics aimed at various tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process to ensure the reproducibility and high purity of its next-generation therapeutics, enabling medical practitioners to address challenging diseases effectively.

Beacon

Series A in 2020
Beacon is a digital supply chain and freight platform developed to optimize supply chains with insights and visibility. It offers a freight forwarding service across all modes integrated with its end-to-end visibility platform, connecting each stage of the supply chain to deliver a record of all the information teams need. From bookings to order management, live tracking, and document management, Beacon will move goods with transparency and efficiency, whilst the secure cloud-based software improves accuracy and saves time. The company was founded in 2018 by Fraser Robinson and Dmitri Izmailov and is headquartered in London, England, United Kingdom.

Hearth

Series A in 2020
Hearth is a financial technology platform that supports home improvement contractors in growing and managing their businesses. The company offers a comprehensive suite of financial tools designed to facilitate business transactions, including financing advice, invoicing, payment collection, and insurance products. By enabling contractors to send quotes, contracts, invoices, and financing options from any location, Hearth streamlines the process of closing deals, ensuring a seamless experience for both contractors and clients.

Octant Bio

Series A in 2020
Octant Bio is a company focused on developing synthetic technology to enhance health and treat diseases. The firm employs synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells simultaneously. This approach allows scientists to use machine learning methods to engineer small molecules that can interact with multiple receptors, offering new potential for treating complex diseases.

Unlearn.AI

Series A in 2020
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Motherly

Series A in 2020
Motherly, Inc. is a digital platform that focuses on supporting millennial mothers throughout their parenting journey, from conception to college. Established in 2015 and based in Menlo Park, California, the company provides a wealth of resources including articles, videos, and guides that cover diverse topics such as parenting advice, wellness tips, and lifestyle content. The platform offers information on various aspects of motherhood, including child-rearing, self-care, home management, beauty, and career coaching. Additionally, Motherly sells a range of products aimed at mothers, including registry essentials and holiday items. The company, formerly known as Motherly Media, Inc., rebranded in March 2018 to better reflect its mission of redefining motherhood and fostering a community-driven lifestyle brand.

MycoWorks

Series A in 2020
MycoWorks is a biotech company that specializes in producing sustainable materials derived from mycelium, the root structure of fungi. By utilizing this natural resource, MycoWorks offers innovative alternatives to conventional plastic foams, synthetic textiles, and leather. Their products are designed to be energy-efficient and biodegradable, catering to various industries, including aerospace, automotive, apparel, and architectural interiors. Through a carbon-negative process, the company transforms agricultural byproducts and mycelium into high-quality materials, allowing clients to access rapidly grown, eco-friendly leather substitutes. MycoWorks aims to address environmental concerns associated with traditional materials while promoting the use of bio-based solutions.

Sonoma Biotherapeutics

Series A in 2020
Sonoma Biotherapeutics, Inc. is focused on developing adoptive T regulatory (Treg) cell therapies aimed at treating autoimmune and degenerative diseases. Established in 2019 and based in South San Francisco, California, with an additional office in Seattle, the company employs next-generation genome editing and target-specific cell therapy techniques to innovate in the field of Treg cell therapeutics. The firm aims to create disease-modifying and potentially curative therapies that promote self-tolerance and inhibit harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded by experts in Treg biology and cell therapy, Sonoma Biotherapeutics integrates advanced methodologies to enhance its therapeutic offerings.

Legalpad

Series A in 2020
Legalpad Inc. is a Seattle-based company that provides a platform designed to streamline the work visa application process, particularly for startups. Founded in 2018 by Sara Itucas, Legalpad focuses on automating repeatable legal tasks and workflows, primarily addressing the complexities associated with O-1, EB-1, H-1B, and B-1 visas. The platform combines intelligent software with human support to facilitate easier and faster visa applications, helping employers and employees navigate the legal landscape of international employment. By connecting global talent with opportunities, Legalpad aims to simplify the legal processes required for individuals seeking to work across borders.

Xilis

Venture Round in 2019
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.

Nines

Series A in 2019
Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Epirus

Venture Round in 2019
Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Jacobi

Series A in 2019
Jacobi, Inc. is a technology company that specializes in providing a customizable platform for the modeling and visualization of multi-asset portfolios. Founded in 2014 and headquartered in San Francisco, California, with additional offices in Brisbane, Australia, and London, United Kingdom, Jacobi offers tools that streamline investment processes, enabling users to design, analyze, and engage with portfolios effectively. The platform aggregates portfolios and cash flows, allowing for the creation of comprehensive dashboards that facilitate intuitive visualizations of complex financial data. By enabling deeper analysis of risk and returns associated with investment decisions, Jacobi enhances communication between investment managers and their clients. The company was previously known as Think Future, Inc. and continues to develop solutions that foster better investment ideas and engagement through storytelling and analytics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.